-
Published 7/8/2026
Pan CX, Mossanen M, Ellis JL, Ma AH, Yang C, Farrukh H, Jiao Y, Bhardwaj U, Lee JS, Lara PN, Hynes C, Lin TY, Li Y, Lerner L, Preston MA, Kibel A, Dall'Era M, Lam KS. Phase I first-in-human dose-escalation trial of a bladder cancer-specific nanoparticle in non-muscle-invasive bladder cancer. Nanomedicine (Lond). 2026 Jul; 21(13):1865-1871. PMID: 42415671.
-
Published 6/30/2026
Gill BC, Rosenberg MT, Kaplan SA, Lerner LB. Management of Persistent Storage Symptoms and Overactive Bladder in Men Diagnosed with Benign Prostatic Hyperplasia: A Narrative Review. Adv Ther. 2026 Sep; 43(9):3765-3785. PMID: 42377740.
-
Published 3/1/2026
Mwafulirwa Z, Goodrich K, Roane A, Andrew A, Lerner LB. Utilization of Real-World Evidence in the Evaluation of Post-Surgical Incontinence in Men Undergoing Surgical Treatment for Benign Prostatic Hyperplasia. Prostate. 2026 May; 86(7):792-799. PMID: 41764777.
-
Published 12/15/2025
Kaplan SA, Parekattil SJ, Wu NZ, Mazzarella B, Trotter M, Freedman S, Lawindy S, Bukkapatnam R, Schwartz BF, Jones B, Sethi P, Jalkut M, Liu JS, Elterman D, Gheiler E, Gonzalez RR, Kaminetsky J, Motola JA, Te A, Chapple C, Lerner L, Lynch T. 12-Month Outcomes From a Randomized, Sham-Controlled Trial Evaluating a Novel Prostatic Urethral Stent for the Treatment of Benign Prostatic Hyperplasia. J Urol. 2026 Apr; 215(4):421-430. PMID: 41396103.
-
Published 8/22/2025
Orlando AP, Maciejko LA, Lerner LB. Nocturia in Men: Is the Prostate Really to Blame? Urol Clin North Am. 2025 Nov; 52(4):581-594. PMID: 41106987.